387 related articles for article (PubMed ID: 28856464)
1. Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.
Liao YT; Yang YH; Kuo TY; Liang HY; Huang KY; Wang TN; Lee Y; McIntyre RS; Chen VC
Eur Child Adolesc Psychiatry; 2018 Mar; 27(3):279-288. PubMed ID: 28856464
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate and the risk of burn injury among children with attention-deficit/hyperactivity disorder.
Chen VC; Yang YH; Yu Kuo T; Lu ML; Tseng WT; Hou TY; Yeh JY; Lee CT; Chen YL; Lee MJ; Dewey ME; Gossop M
Epidemiol Psychiatr Sci; 2020 Jul; 29():e146. PubMed ID: 32686635
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate and TBI in ADHD and co-occurring epilepsy and mental disorders: a self-controlled case series study.
Chen VC; Yang YH; Lee CT; Chen YL; Dewey ME; Gossop M
Eur Child Adolesc Psychiatry; 2022 Feb; 31(2):361-368. PubMed ID: 33389157
[TBL] [Abstract][Full Text] [Related]
4. Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.
Wang LJ; Yang KC; Lee SY; Yang CJ; Huang TS; Lee TL; Yuan SS; Shyu YC
PLoS One; 2016; 11(8):e0161061. PubMed ID: 27518196
[TBL] [Abstract][Full Text] [Related]
5. Short-term efficacy and tolerability of methylphenidate in children with traumatic brain injury and attention problems.
Ekinci O; Direk MÇ; Gunes S; Teke H; Ekinci N; Yıldırım F; Okuyaz Ç
Brain Dev; 2017 Apr; 39(4):327-336. PubMed ID: 27903419
[TBL] [Abstract][Full Text] [Related]
6. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
[TBL] [Abstract][Full Text] [Related]
7. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies.
Jin C; Schachar R
CNS Spectr; 2004 Mar; 9(3):217-26. PubMed ID: 14999162
[TBL] [Abstract][Full Text] [Related]
9. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
Liu YC; Chen VC; Yang YH; Chen YL; Gossop M
Epidemiol Psychiatr Sci; 2021 Feb; 30():e14. PubMed ID: 33583471
[TBL] [Abstract][Full Text] [Related]
10. Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: A Taiwan nationwide population-based cohort study.
Liang SH; Yang YH; Kuo TY; Liao YT; Lin TC; Lee Y; McIntyre RS; Kelsen BA; Wang TN; Chen VC
Res Dev Disabil; 2018 Jan; 72():96-105. PubMed ID: 29121517
[TBL] [Abstract][Full Text] [Related]
11. Risk of Traumatic Brain Injury Among Children, Adolescents, and Young Adults With Attention-Deficit Hyperactivity Disorder in Taiwan.
Liou YJ; Wei HT; Chen MH; Hsu JW; Huang KL; Bai YM; Su TP; Li CT; Yang AC; Tsai SJ; Lin WC; Chen TJ
J Adolesc Health; 2018 Aug; 63(2):233-238. PubMed ID: 29970331
[TBL] [Abstract][Full Text] [Related]
12. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
[TBL] [Abstract][Full Text] [Related]
13. Impact of negative media publicity on attention-deficit/hyperactivity disorder medication in Taiwan.
Wang LJ; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Shyu YC
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):45-53. PubMed ID: 26549311
[TBL] [Abstract][Full Text] [Related]
14. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
15. Testicular Function After Long-Term Methylphenidate Treatment in Boys with Attention-Deficit/Hyperactivity Disorder.
Wang LJ; Lee SY; Chou WJ; Lee MJ; Tsai CS; Lee TL; Yang CJ; Yang KC; Chen CK; Shyu YC
J Child Adolesc Psychopharmacol; 2019 Aug; 29(6):433-438. PubMed ID: 30575416
[No Abstract] [Full Text] [Related]
16. The use of methylphenidate in paediatric traumatic brain injury.
Hornyak JE; Nelson VS; Hurvitz EA
Pediatr Rehabil; 1997; 1(1):15-7. PubMed ID: 9689233
[TBL] [Abstract][Full Text] [Related]
17. Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.
Scholle O; Banaschewski T; Enders D; Garbe E; Riedel O
J Child Adolesc Psychopharmacol; 2018; 28(6):415-422. PubMed ID: 29768038
[TBL] [Abstract][Full Text] [Related]
18. The risk of injury in adults with attention-deficit hyperactivity disorder: A nationwide, matched-cohort, population-based study in Taiwan.
Chien WC; Chung CH; Lin FH; Yeh CB; Huang SY; Lu RB; Chang HA; Kao YC; Chiang WS; Chou YC; Tsao CH; Wu YF; Tzeng NS
Res Dev Disabil; 2017 Jun; 65():57-73. PubMed ID: 28458048
[TBL] [Abstract][Full Text] [Related]
19. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
20. Association of traumatic brain injury in childhood and attention-deficit/hyperactivity disorder: a population-based study.
Yang LY; Huang CC; Chiu WT; Huang LT; Lo WC; Wang JY
Pediatr Res; 2016 Sep; 80(3):356-62. PubMed ID: 27064246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
